Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.

The site of action of aminoglutethimide (AG) has been investigated. An initial study was performed on 10 postmenopausal patients with advanced breast cancer who had taken 1000 mg AG per day and 20 mg hydrocortisone (HC) twice daily (b.d.) for greater than 3 months. There was a 15.5 +/- 5.6 s.e.-fold...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Harris, A. L., Dowsett, M., Smith, I. E., Jeffcoate, S. L.
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 1983
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2011397/
https://ncbi.nlm.nih.gov/pubmed/6221746
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky